A Novel Antibody-TCR (AbTCR) Platform Combines Fab-Based Antigen Recognition With Gamma/Delta-TCR Signaling to Facilitate T-Cell Cytotoxicity With Low Cytokine Release
Cell Discovery - United Kingdom
doi 10.1038/s41421-018-0066-6
Full Text
Open PDFAbstract
Available in full text
Date
November 20, 2018
Authors
Publisher
Springer Science and Business Media LLC